LONDON (Alliance News) - Futura Medical PLC said Monday that its own-brand of its novel CSD500 condom has captured an estimated 15% share of the Netherlands online condom market by value in its first month since launching.
The condom is lined with a gel that the company promises will increase blood flow, giving bigger, firmer erections and a longer lasting sexual experience for women.
Futura said the product has attracted "considerable" local media coverage, customer feedback has been favourable, and it has started to see repeat buying of Blue Diamond. It is currently reviewing interest from other e-tailers hoping to see the product, and expects to make if available at further outlets for Dutch and Belgian customers.
"We have been approached by a considerable number of e-tailers and retailers interested in stocking the product and it is our intention to widen local distribution as part of our strategy to drive awareness of the product and grow sales, said Chief Executive James Barder in a statement.
Shares in Futura are trading up 3.5% at 41.40 pence Monday morning.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright 2014 Alliance News Limited. All Rights Reserved.
Futura Medical (FUM)